OBJECTIVE: To propose a common nomenclature to refer to individuals who fulfill the American College of Rheumatology classification criteria for systemic lupus erythematosus (SLE) during childhood or adolescence. METHODS: The medical literature was reviewed for studies conducted in the target population between 1960 and December 2011 to obtain information about the terms used to refer to such children and adolescents. We reviewed the threshold ages used and disease features considered to discriminate these individuals from patients with onset of SLE during adulthood. Furthermore, the nomenclature used in other chronic diseases with onset during both childhood and adulthood was assessed. RESULTS: There was an astonishing variability in the age cutoffs used to define SLE onset prior to adulthood, ranging from 14-21 years, but most studies used age 18 years. The principal synonyms in the medical literature were SLE without reference to the age at onset of disease, childhood-onset SLE, juvenile SLE, and pediatric (or paediatric) SLE. CONCLUSION: Based on the definition of childhood, in analogy with other complex chronic diseases commencing prior to adulthood, and given the current absence of definite genetic variations that discriminate adults from children, the term childhood-onset SLE is proposed when referring to individuals with onset of SLE prior to age 18 years.
OBJECTIVE: To propose a common nomenclature to refer to individuals who fulfill the American College of Rheumatology classification criteria for systemic lupus erythematosus (SLE) during childhood or adolescence. METHODS: The medical literature was reviewed for studies conducted in the target population between 1960 and December 2011 to obtain information about the terms used to refer to such children and adolescents. We reviewed the threshold ages used and disease features considered to discriminate these individuals from patients with onset of SLE during adulthood. Furthermore, the nomenclature used in other chronic diseases with onset during both childhood and adulthood was assessed. RESULTS: There was an astonishing variability in the age cutoffs used to define SLE onset prior to adulthood, ranging from 14-21 years, but most studies used age 18 years. The principal synonyms in the medical literature were SLE without reference to the age at onset of disease, childhood-onset SLE, juvenile SLE, and pediatric (or paediatric) SLE. CONCLUSION: Based on the definition of childhood, in analogy with other complex chronic diseases commencing prior to adulthood, and given the current absence of definite genetic variations that discriminate adults from children, the term childhood-onset SLE is proposed when referring to individuals with onset of SLE prior to age 18 years.
Authors: Samuel K Shinjo; Eloísa Bonfá; Daniel Wojdyla; Eduardo F Borba; Luis A Ramirez; Hugo R Scherbarth; João C Tavares Brenol; Rosa Chacón-Diaz; Oscar J Neira; Guillermo A Berbotto; Ignacio Garcia De La Torre; Eduardo M Acevedo-Vázquez; Loreto Massardo; Leonor A Barile-Fabris; Francisco Caeiro; Luis H Silveira; Emilia I Sato; Sandra Buliubasich; Graciela S Alarcón; Bernardo A Pons-Estel Journal: Arthritis Rheum Date: 2010-03
Authors: A A Jesus; C A Silva; M Carneiro-Sampaio; M Sheinberg; C L Mangueira; S K Marie; B L Liphaus Journal: Ann N Y Acad Sci Date: 2009-09 Impact factor: 5.691
Authors: Hermine I Brunner; Michael R Bennett; Khalid Abulaban; Marisa S Klein-Gitelman; Kathleen M O'Neil; Lori Tucker; Stacy P Ardoin; Kelly A Rouster-Stevens; Karen B Onel; Nora G Singer; B Anne Eberhard; Lawrence K Jung; Lisa Imundo; Tracey B Wright; David Witte; Brad H Rovin; Jun Ying; Prasad Devarajan Journal: Arthritis Care Res (Hoboken) Date: 2016-07 Impact factor: 4.794
Authors: Hermine I Brunner; Michael R Bennett; Gaurav Gulati; Khalid Abulaban; Marisa S Klein-Gitelman; Stacy P Ardoin; Lori B Tucker; Kelly A Rouster-Stevens; David Witte; Jun Ying; Prasad Devarajan Journal: J Rheumatol Date: 2017-06-15 Impact factor: 4.666
Authors: Fernanda J Fiorot; Aline G Islabão; Rosa M Pereira; Maria T Terreri; Claudia Saad-Magalhães; Glaucia V Novak; Beatriz C Molinari; Ana P Sakamoto; Nadia E Aikawa; Lucia M Campos; Octavio A Peracchi; Simone Appenzeller; Virgínia P Ferriani; Marco F Silva; Adriana R Fonseca; Flávio R Sztajnbok; Luciana B Paim; Melissa M Fraga; Eunice M Okuda; Blanca E Bica; Evaldo G Sena; Ana J Moraes; Ana M Rolim; Paulo F Spelling; Iloite M Scheibel; André S Cavalcanti; Erica N Matos; Teresa C Robazzi; Luciano J Guimarães; Flávia P Santos; Valeria C Ramos; Magda Carneiro-Sampaio; Eloisa Bonfá; Clovis A Silva Journal: Clin Rheumatol Date: 2019-06-13 Impact factor: 2.980
Authors: Hermine I Brunner; Gaurav Gulati; Marisa S Klein-Gitelman; Kelly A Rouster-Stevens; Lori Tucker; Stacey P Ardoin; Karen B Onel; Rylie Mainville; Jessica Turnier; Pinar Ozge Avar Aydin; David Witte; Bin Huang; Michael R Bennett; Prasad Devarajan Journal: Pediatr Nephrol Date: 2018-08-29 Impact factor: 3.714
Authors: Ana Paula Sakamoto; Clovis Artur Silva; Mariana Paes Leme Ferriani; Rosa Maria Rodrigues Pereira; Eloisa Bonfá; Claudia Saad-Magalhães; Eunice Okuda; Simone Appenzeller; Francisco Hugo Gomes; Ana Luiza Garcia Cunha; Mirna Henriques Tomich Salume; Daniela Petry Piotto; Maria Teresa Terreri Journal: Rheumatol Int Date: 2016-09-14 Impact factor: 2.631
Authors: Hermine I Brunner; Michael J Holland; Michael W Beresford; Stacy P Ardoin; Simone Appenzeller; Clovis A Silva; Francisco Flores; Beatrice Goilav; Pinar Ozge Avar Aydin; Scott E Wenderfer; Deborah M Levy; Angelo Ravelli; Raju Khubchandani; Tadej Avcin; Marisa S Klein-Gitelman; Nicolino Ruperto; Brian M Feldman; Jun Ying Journal: Arthritis Care Res (Hoboken) Date: 2019-05 Impact factor: 4.794